
A single batch of blood pressure pills shipped to pharmacies nationwide may contain tiny bits of metal sharp enough to cut a patient’s throat or stomach.
Story Snapshot
- Breckenridge Pharmaceutical recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, 60 mg, over possible metal contamination.
- The affected bottles carry lot number PK25110035 and expire in May 2029.
- The company says the metal could cut the mouth, throat, stomach, or intestines if swallowed.
- No injuries have been reported so far, and the drug was shipped nationwide between October 26 and November 4, 2026.
What Triggered The Recall
Breckenridge Pharmaceutical issued a voluntary nationwide recall on November 16 for one lot of propranolol, a common heart and blood pressure drug. The company said the capsules may contain metal fragments that could injure patients. The affected product comes in 100-count bottles under NDC 51991-817-01, with lot number PK25110035 and an expiration date of May 2029.
Breckenridge said the contamination risk is real but specific. The company explained that the recalled lot “shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market.” That second, unreleased lot is where the metal was actually confirmed, raising questions about exactly how much, if any, made it into pills patients already took home.
The Health Risk Explained In Plain Terms
Breckenridge warned that swallowing a contaminated capsule “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine.” In simple terms, that means cuts inside the mouth, throat, or gut. As of the announcement, the company had not received any reports of patients getting hurt.
Propranolol is a beta-blocker. Doctors prescribe it for high blood pressure, irregular heartbeats, and other heart problems. People who stop taking heart medicine suddenly can face serious health risks of their own. That is why Breckenridge did not simply tell patients to quit the drug cold turkey.
What Patients And Pharmacies Should Do Now
Breckenridge told anyone with the affected lot to stop using it immediately. The company urged patients to call their doctor or pharmacist right away to get a replacement prescription instead of going without their medicine. Consumers were also told to return any unused capsules to the pharmacy where they were bought.
Wholesalers and pharmacies that received the lot were told to check their shelves and pull any remaining bottles. Breckenridge said the product went out nationwide between October 26 and November 4, 2026, meaning pharmacies across the country could have received shipments during that nine-day window.
💊 BLOOD PRESSURE MEDICATION RECALLED NATIONWIDE OVER POSSIBLE METAL CONTAMINATION
Breckenridge Pharmaceutical Inc. issued a voluntary nationwide recall for one lot of 60 mg propranolol hydrochloride extended-release capsules (lot PK25110035, expiring May 2029) over potential…
— Erik Hoffmann (@TheErikHoffmann) November 17, 2026
Where The Manufacturing Trail Leads
Adare Pharma Solutions, based in New Jersey, manufactured the capsules for Breckenridge. Public materials do not reveal how the suspected metal got into the production process or what type of metal might be involved. No lab results, photos, or inspection reports have been made public showing exactly what was found or where.
Federal recall rules do not require a company to prove every single bottle is contaminated before acting. The Food and Drug Administration (FDA) instructs manufacturers to evaluate which lots might be affected once foreign material turns up anywhere in a shared production stream, not just the specific batch where it was confirmed. That standard appears to be what pushed Breckenridge to pull this lot as a precaution.
This recall fits a pattern familiar to anyone who follows drug safety news. The FDA’s own recall records show repeated cases of particulate contamination in medicines, from glass shards to cellulose fibers to stainless steel, across companies large and small. For patients, the practical message stays the same regardless of the exact cause: check your bottle’s lot number, and if it matches, call your pharmacist before your next dose.
Sources:
washingtontimes.com, prnewswire.com, kmbc.com, wtsp.com, kbtx.com, houstonchronicle.com


